Milestone Pharmaceuticals Inc.

8-K Director or officer change; Shareholder vote results Jun 15, 2026 8-K Results of operations (earnings release) May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) Mar 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 20, 2026 8-K Other events Jan 26, 2026 8-K Other events Jan 13, 2026 8-K Other events Jan 6, 2026 8-K Regulation FD disclosure; Other events Dec 15, 2025 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Entered a material agreement; Other events Jul 14, 2025 8-K Entered a material agreement; Other events Jul 11, 2025 8-K Other events Jun 16, 2025 8-K Director or officer change; Shareholder vote results Jun 12, 2025 8-K Results of operations (earnings release) May 14, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Other events Mar 28, 2025 8-K Item 5.08 Mar 19, 2025 8-K Entered a material agreement; Other events Mar 18, 2025 8-K Results of operations (earnings release) Mar 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Regulation FD disclosure Feb 25, 2025 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Director or officer change; Shareholder vote results; Regulation FD disclosure Sep 4, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Entered a material agreement; Director or officer change; Item 5.08; Other events Jul 15, 2024 8-K Other events May 29, 2024 8-K Results of operations (earnings release) May 13, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 29, 2024 8-K Other events Apr 8, 2024 8-K Other events Mar 28, 2024 8-K Results of operations (earnings release) Mar 21, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Entered a material agreement; Other events Mar 4, 2024